Nonalcoholic Steatohepatitis [dsyn]    
Therapeutic [topp]    
Challenge [clna]    
Global [spco]    
Epidemic [phpr]    
Purpose [ftcn]    
Non-alcoholic fatty liver [dsyn]    
Inflammatory [ftcn]    
Variant [qlco]    
Nonalcoholic Steatohepatitis [dsyn]    
Challenge [clna]    
Systems, Healthcare [hcro]    
Increasing [ftcn]    
Risk Factors [qnco]    
OBESITY [dsyn]    
Type II Diabetes [dsyn]    
Link [inpr]    
Overeating [fndg]    
Physical Inactivity [dora]    
METABOLIC SYNDROME [dsyn]    
findings [ftcn]    
Patients [podg]    
Non-alcoholic fatty liver [dsyn]    
Nonalcoholic Steatohepatitis [dsyn]    
progress [ftcn]    
CIRRHOSIS [dsyn]    
End Stage Liver Disease [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
Mortality [qnco]    
Patients [podg]    
Increased [qnco]    
Cardiovascular [bdsy]    
hepatic complications [patf]    
Related [qlco]    
Sustained [ftcn]    
WEIGHTLOSS [fndg]    
Diet [food]    
Exercise [dora]    
effective [qlco]    
Therapeutic [topp]    
Measure [qnco]    
Minority [popg]    
Patients [podg]    
LED [mnob]    
Great [qnco]    
Unmet [acty]    
Need [qlco]    
Medical therapies [topp]    
Nonalcoholic Steatohepatitis [dsyn]    
summary [inpr]    
pharmacologic therapy [ftcn]    
Target [ftcn]    
pathophysiology [ftcn]    
INSULIN RESISTANCE [patf]    
Enhanced [acty]    
PERIPHERAL [spco]    
Lipolysis [orgf]    
Release [hlca]    
Free Fatty Acids [orch]    
Oxidative Stress [comd]    
ACCUMULATION [fndg]    
toxic [inpo]    
Lipids [orch]    
ADIPOSE TISSUE [tisu]    
INFLAMMATION [patf]    
Sensitization [orgf]    
Hepatocytes [cell]    
apoptotic cell death [celf]    
fibrogenesis [orgf]    
pharmacologic therapy [ftcn]    
Well [qlco]    
Cost Effectiveness [qnco]    
Acceptable [qlco]    
Risk Ratio [qnco]    
Benefit [qnco]    
Identified [qlco]    
CURRENT [tmco]    
promise [idcn]    
treatment options [topp]    
Future [tmco]    
Research [resa]    
practice [menp]    
